A federal jury in California has found that Apple infringed on a Masimo patent for its pulse oximetry technology and awarded Masimo $634 million in damages, Masimo said Friday.

“This is a significant win in our ongoing efforts to protect our innovations and intellectual property, which is crucial to our ability to develop technology that benefits patients,” the company said in a statement. “We remain committed to defending our IP rights moving forward.”

Apple told MedTech Dive it would appeal the verdict.

The tech giant disagrees with the decision, which it believes is contrary to the facts, an Apple spokesperson said in an emailed statement. “Masimo is a medical device company that does not sell any products to consumers,” the spokesperson said.

The two c

See Full Page